642 related articles for article (PubMed ID: 34522705)
1. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
Zhang B; Jiang H; Dong Z; Sun A; Ge J
Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
[TBL] [Abstract][Full Text] [Related]
2. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
5. Function of N6-Methyladenosine Modification in Tumors.
Zhang N; Zuo Y; Peng Y; Zuo L
J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
[TBL] [Abstract][Full Text] [Related]
8. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
[TBL] [Abstract][Full Text] [Related]
9. RNA m6A methylation regulators in sepsis.
Zhu L; Zhang H; Zhang X; Xia L
Mol Cell Biochem; 2023 Sep; ():. PubMed ID: 37659034
[TBL] [Abstract][Full Text] [Related]
10. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
11. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
[TBL] [Abstract][Full Text] [Related]
12. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
13. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
Liu WW; Wang H; Zhu XY
Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
15. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
[TBL] [Abstract][Full Text] [Related]
16. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
Chang H; Yang J; Wang Q; Zhao J; Zhu R
Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
[TBL] [Abstract][Full Text] [Related]
17. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
18. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.
Song N; Cui K; Zhang K; Yang J; Liu J; Miao Z; Zhao F; Meng H; Chen L; Chen C; Li Y; Shao M; Zhang J; Wang H
Front Pharmacol; 2022; 13():933332. PubMed ID: 35784761
[TBL] [Abstract][Full Text] [Related]
19. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine and Neurological Diseases.
Zhang N; Ding C; Zuo Y; Peng Y; Zuo L
Mol Neurobiol; 2022 Mar; 59(3):1925-1937. PubMed ID: 35032318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
